bioRxiv · 10.1101/2023.03.13.531514
An O-GlcNAc transferase pathogenic variant that affects pluripotent stem cell self-renewal
Abstract
O-linked {beta}-N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential enzyme that modifies proteins with O-GlcNAc. Inborn OGT genetic variants were recently shown to mediate a novel type of Congenital Disorder of Glycosylation (OGT-CDG) which is characterized by X-linked intellectual disability (XLID) and developmental delay. Here, we report an OGTC921Y variant which co-segregates with XLID and epileptic seizures, and results in loss of catalytic activity. Colonies formed by mouse embryonic stem cells carrying OGTC921Y show decreased levels of protein O-GlcNAcylation accompanied by decreased levels of Oct4, Sox2 and extracellular alkaline phosphatase (ALP), implying reduced self-renewal capacity. These data establish a link between OGT-CDG and embryonic stem cell self-renewal, providing a foundation for examining the developmental aetiology of this syndrome. Summary statementWe show that the C921Y O-GlcNAc transferase variant found in patients with intellectual disability leads to a defect in pluripotent stem cell self-renewal and decreased levels of stem cell markers.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Omelkova, M., Fenger, C. D., Murray, M., Hammer, T. B., Pravata, V. M., Bartual, S., Czajewski, I., Bayat, A., Ferenbach, A. T., Stavridis, M., van Aalten, D. M. F.. 2023-03-13. An O-GlcNAc transferase pathogenic variant that affects pluripotent stem cell self-renewal. https://doi.org/10.1101/2023.03.13.531514
Cite the original work for its findings. Save a collection to share your selection of sources.